This Co. is flying under the radar with patents to many proprietary drugs and products which will be commercialized in 2013 which is a milestone for this company as it tranforms from a research co. to a profitable business. At the very least the pumping is putting this on many investors radar. As it goes over a penny ...many will jump on board